RNAC vs SWK · P/E 2.1, rev $78.0K vs P/E 34, rev $7.81B
Cartesian Therapeutics Inc. (RNAC) versus Stanley Black & Decker Inc (SWK) — a side-by-side from cached financials, not a winner call.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Stanley Black & Decker Inc (SWK) is a tools & accessories company listed on NYSE.
Latest reported RNAC revenue for 2026-06-30 was $78.0K. Net income was -$23.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Latest reported SWK revenue for 2026-07-04 was $7.81B. Net income was $410.9M. SWK currently screens at market cap $12.82B and trailing P/E 33.8.
RNAC currently screens at market cap $290.9M and trailing P/E 2.1. SWK currently screens at market cap $12.82B and trailing P/E 33.8.
Not investment advice. Open the RNAC and SWK stock pages for the full models.
Not investment advice.